Log in to your Inderes Free account to see all free content on this page.
Klaria Pharma Holding
0.95 SEK
+1.49 %
Less than 1K followers
KLAR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+1.49 %
+16.38 %
+42.94 %
+42.94 %
+98.75 %
-22.49 %
+33.97 %
-87.41 %
-79.17 %
Klaria Pharma Holding operates in the pharmaceutical industry. The business is focused on developing and commercializing solutions in the therapeutic areas of migraine and cancer-related pain. The technology is based on the company's drug-delivery platform, where the product consists of an alginate-based polymer film. The film is attached to the patient's oral mucosa, which enables the distribution of drugs in the body. The headquarters are located in Uppsala.
Read moreMarket cap
234.17M SEK
Turnover
435.2K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5.
2026
General meeting '26
21.5.
2026
Interim report Q1'26
27.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ)
Klaria Pharma Holding AB (publ) Summons to Extraordinary General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio